References

Cui, Z.H., 2005. DNA vaccine. Adv. Genet., 54: 257-289.
CrossRef  |  PubMed  |  Direct Link  |  

Hooton, M.T., 2001. Recurrent urinary tract infection in women. Int. J. Antimicrobial Agents, 17: 259-268.
CrossRef  |  PubMed  |  Direct Link  |  

Hopkins, J.W, M.D. Heisey and T.D. Uehling, 1999. Association of human leukocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection. Vaccine, 17: 169-171.
CrossRef  |  PubMed  |  Direct Link  |  

Johnson, R.J., 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev., 4: 80-128.
PubMed  |  Direct Link  |  

Justice, S.S., C.H. Hung, A.J. Theriot, A.D. Fletcher, G.G. Anderson, J.M. Footer and S.S. Hultgren, 2004. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA., 101: 1333-1338.
CrossRef  |  PubMed  |  Direct Link  |  

Kozak, M., 2002. Pushing the limits of the scanning mechanism for initiation of translation. Gene, 299: 1-34.
CrossRef  |  PubMed  |  Direct Link  |  

Langermann, S. and W.R. Ballou, 2001. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infection. J. Infect. Dis., 183: 84-86.
CrossRef  |  PubMed  |  Direct Link  |  

Langermann, S., R. Mollby, E.L. Burlein, R.S. Palaszynski and G. Auguste et al., 2000. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by Uropathogenic Escherichia coli. J. Infect. Dis., 181: 774-778.
CrossRef  |  PubMed  |  Direct Link  |  

Langermann, S., S. Palaszynski, M. Barnhart, G. Auguste and S.J. Pinkner et al ., 1997. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science, 276: 607-611.
CrossRef  |  PubMed  |  Direct Link  |  

Martinez, J.J., A.M. Mulvey, D.J. Schilling, S.J. Pinkner and J.S. Hultgren, 2000. Type1 pilus mediated bacterial invasion of bladder epithelial cells. EMBO J., 19: 2803-2812.
CrossRef  |  PubMed  |  Direct Link  |  

Mysorekar, I.U. and J.S. Hultgren, 2006. Mechanisms of Uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad.Sci., USA., 103: 14170-14175.
CrossRef  |  PubMed  |  Direct Link  |  

Reigstad, S., J.S. Ch. Hultgren and I.J. Gordon, 2007. Functional genomic studies of Uropathogenic E. coli and host urothelial cells when intracellular bacterial communities are assembled. J. Biol. Chem., 282: 21259-21267.
CrossRef  |  PubMed  |  Direct Link  |  

Sambrook, J., P. MacCallum and D. Russell, 2001. Molecular Cloning: A Laboratory Manual. 3rd Edn., Cold Spring Harbor Laboratory Press, New York, USA.

Snyder, A.J., J.B. Haugen, C.V. Lockatell, N. Maroncle and C.E. Hagan et al., 2005. coordinate expression of fimbriae in Uropathogenic Escherichia coli. Infection Immunity, 73: 7588-7596.
CrossRef  |  PubMed  |  Direct Link  |  

Sokurenko V.E., M. Feldgarden, E. Trintchina J.S. Weissman and S. Avagyan et al., 2004. selection footprint in the fimh adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol. Biol. Evol., 21: 1373-1383.
CrossRef  |  PubMed  |  Direct Link  |  

Yong-Hwa, L., D.K. Ryu, B.O. Kim, and S. Pyo, 2003. Expression and characterization of Uropathogenic Escherichia coli adhesin protein linked to cholera toxin a2b subunit in escherichia coli tb1. J. Mic. Biotechnol., 13: 552-559.
Direct Link  |